Drs. Kalunian, Furie, Putterman, Ramsey-Goldman, Buyon, and Weinstein have received honoraria for serving on the Exagen Diagnostics advisory board (less than $10,000 each).
Systemic Lupus Erythematosus
Measurement of cell-bound complement activation products enhances diagnostic performance in systemic lupus erythematosus
Version of Record online: 28 NOV 2012
Copyright © 2012 by the American College of Rheumatology
Arthritis & Rheumatism
Volume 64, Issue 12, pages 4040–4047, December 2012
How to Cite
Kalunian, K. C., Chatham, W. W., Massarotti, E. M., Reyes-Thomas, J., Harris, C., Furie, R. A., Chitkara, P., Putterman, C., Gross, R. L., Somers, E. C., Kirou, K. A., Ramsey-Goldman, R., Hsieh, C., Buyon, J. P., Dervieux, T. and Weinstein, A. (2012), Measurement of cell-bound complement activation products enhances diagnostic performance in systemic lupus erythematosus. Arthritis & Rheumatism, 64: 4040–4047. doi: 10.1002/art.34669
- Issue online: 28 NOV 2012
- Version of Record online: 28 NOV 2012
- Accepted manuscript online: 29 AUG 2012 03:08PM EST
- Manuscript Accepted: 7 AUG 2012
- Manuscript Received: 2 MAY 2012
- Exagen Diagnostics
- 14Diagnostic and Therapeutic Criteria Committee of the American College of Rheumatology. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997; 40: 1725., for the
- 16BLISS-76 Study Group. A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus. Arthritis Rheum 2011; 63: 3918–30., , , , , , et al, for the
- 19Approximate is better than “exact” for interval estimation of binomial proportions. Am Statist 1998; 52: 119–26., .
- 20Clinical prediction models: a practical approach to development, validation and updating. New York: Springer-Verlag; 2009., .